Produkty 18462-31-2

CAS 18462-31-2 występuje w naszej ofercie pod nazwami: (3Beta,13Alpha)-3-(Acetyloxy)androst-5-en-17-one, >95% (HPLC), (3b,13a)-3-(Acetyloxy)androst-5-en-17-one, >95% (HPLC), (3β,13α)-3-(Acetyloxy)androst-5-en-17-one. Oferty producentów: TRC, Mikromol. Dostępne opakowania: 1g, 2,5g, 5g, 25mg.

(3Beta,13Alpha)-3-(Acetyloxy)androst-5-en-17-one, >95% (HPLC)
TRC
  • opakowanie: 1g
  • Warianty: 1
Zobacz produkt
(3b,13a)-3-(Acetyloxy)androst-5-en-17-one, >95% (HPLC)
TRC
  • opakowanie: 2,5g, 5g
  • Warianty: 2
Zobacz produkt
(3β,13α)-3-(Acetyloxy)androst-5-en-17-one
Mikromol
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(3S,8R,9S,10R,13R,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate (CAS 18462-31-2) to związek chemiczny o wzorze sumarycznym C21H30O3 i masie molowej 330.5 g/mol. Nazwa systematyczna IUPAC: [(3S,8R,9S,10R,13R,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate. InChIKey: NCMZQTLCXHGLOK-JPRZGNOKSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O3
Masa molowa330.5 g/mol
Nazwa IUPAC[(3S,8R,9S,10R,13R,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate
InChIKeyNCMZQTLCXHGLOK-JPRZGNOKSA-N
SMILESCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@@]4([C@H]([C@@H]3CC=C2C1)CCC4=O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: (3b,13a)-3-(Acetyloxy)androst-5-en-17-one, 3beta-Acetoxy-13alpha-androst-5-en-17-one, (3beta,13alpha)-3-(Acetyloxy)androst-5-en-17-one, 17-Oxo-13alpha-androst-5-en-3beta-yl acetate
Powiązane formy tego związku
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate C21H30O3
[(3R,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate C21H30O3
Izomery (ten sam wzór sumaryczny)
(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,4,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O3
(1R,2R,4R,5R,7S,10R,11S,14S,16S,18S,19S)-5,7-dihydroxy-10,14-dimethylhexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecan-15-one C21H30O3
(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol C21H30O3
(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O3
methyl (8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-17-carboxylate C21H30O3
[(7R,8R,9S,10R,13S,14S,17S)-7,13-dimethyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C21H30O3
[(1S,2S,4R,6S,8S,11R,12S,16S)-2,16-dimethyl-5-oxapentacyclo[9.7.0.02,8.04,6.012,16]octadec-14-en-15-yl] acetate C21H30O3
(8S,9S,10R,13S,14S,16R,17R)-17-acetyl-16-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O3
(6R,8S,9S,10R,13S,14S,17S)-17-acetyl-6-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O3
(2E,4E,6E,8E)-9-(3-methoxy-2,6,6-trimethylcyclohexen-1-yl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid C21H30O3